Table 1. Demographics and clinical characteristics of PKDL patients (N = 50).

Variables	Group A (N = 25)	Group B (N = 25)	p value
Age in years
Mean(±SD)	19.8(5.9)	22.25(9.5)	0.28
Sex
Male	11(44%)	13(52%)	0.38
Female	14(56%)	12(48%)
Past history of VL
Yes	21(84%)	19(76%)	0.36
No	4(16%)	6(24%)
Past history of VL
Yes	13(52%)	8(32%)	0.12
No	12(48%)	17(68%)
Previous treatment for VL
SAG	13(62%)	17(89.5%)	0.19
Miltefosine	6(29%)	1(5.2%)	0.04
Paromomycin	0	1(5.2%)	-
Ambisome	1(4.7%)	0	-
Amphotericin B	1(4.7%)	0	-
Type of Lesion
Macular	10(40%)	9(36%)	0.5
Papular	2(8%)	4(16%)	0.33
Maculopapular	8(32%)	10(40%)	0.38
Nodular	5(20%)	2(8%)	0.2

VL: Visceral leishmaniasis, SAG: Sodium antimony gluconate.